Advertisement
Screener

The Vita Coco Company, Inc. (COCO) Spending and interest coverage

The Vita Coco Company, Inc. (COCO) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months(m)Share-based compensation / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)Research and Development Expense
Revenue(m)
Stock-based compensation13.91M USDShare-based Payment Arrangement, Noncash Expense
Operating income134.84M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30(m)(m)$13.91M$134.84M(m)(m)(m)(m)(m)
2026-03-31(m)(m)$13.28M$96.82M(m)(m)(m)(m)(m)
2025-12-31$399.00K(m)$10.84M$82.53M(m)(m)(m)(m)(m)
2025-09-30(m)(m)$10.40M$76.62M(m)(m)(m)(m)(m)
2025-06-30(m)(m)$9.56M$69.30M(m)(m)(m)(m)(m)
2025-03-31(m)(m)$9.00M$74.15M(m)(m)(m)(m)(m)
2024-12-31$398.00K(m)$8.92M$73.82M(m)(m)(m)(m)(m)
2024-09-30(m)(m)$8.65M$74.96M$0.00(m)(m)(m)Reported
2024-06-30(m)(m)$9.37M$77.88M$1.00K(m)(m)77884.00×Reported
2024-03-31(m)(m)$9.07M$68.75M$16.00K(m)(m)4296.75×Reported
2023-12-31$418.00K(m)$9.13M$56.49M$31.00K(m)(m)1822.35×Reported
2023-09-30(m)(m)$8.85M$46.22M$76.00K(m)(m)608.11×Reported
2023-06-30(m)(m)$7.45M$31.31M$205.00K(m)(m)152.73×Reported
2023-03-31(m)(m)$7.16M$15.50M$246.00K(m)(m)63.00×Reported
2022-12-31$541.00K(m)$7.38M$3.06M$258.00K(m)(m)11.84×Reported
2022-09-30(m)(m)$7.40M$2.83M$254.00K(m)(m)11.16×Reported
2022-06-30(m)(m)$6.57M$12.04M$251.00K(m)(m)47.99×Reported
2022-03-31(m)(m)$5.28M$14.54M$308.00K(m)(m)47.22×Reported
2021-12-31$477.00K(m)$3.38M$24.59M$360.00K(m)(m)68.30×Reported
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31$313.00K(m)$1.52M$46.86M$791.00K(m)(m)59.24×Reported
2020-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31$642.00K(m)$2.23M$13.37M$1.16M(m)(m)11.50×Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Westrock Coffee Co (WEST)United States$0.778B-12.41
BUDA JUICE, INC. (BUDA)United States$0.094B
SRX Global Inc. (SRXH)United States$0.035B
WILLAMETTE VALLEY VINEYARDS INC (WVVI)United States$0.009B
AMASS BRANDS (AMSS)United States$0.008B
IP STRATEGY HOLDINGS, INC. (IPST)United States$0.002B-0.00
LQR House Inc. (YHC)United States$0.002B
Primo Brands Corp (PRMB)United States$7.004B88.25
Keurig Dr Pepper Inc. (KDP)United States$42.036B31.21
PEPSICO INC (PEP)United States$174.877B18.87